Skip to main content
Top Button
Rescheduling or Descheduling: How Future Federal Decisions May Impact the Industry Rescheduling or Descheduling: How Future Federal Decisions May Impact the Industry

Rescheduling or Descheduling: How Future Federal Decisions May Impact the Industry

 
Following President Biden’s Oct. 6 announcement that his administration will review the status of cannabis under federal law, the industry is now wondering: What does that mean for us? This review could ultimately result in rescheduling the plant to another classification under the Controlled Substances Act or descheduling the plant entirely—or nothing may happen at all. Rescheduling cannabis would send it down a regulatory pathway much different than the current state-by-state structure; the U.S. Food and Drug Administration would inevitably be involved. Descheduling the plant would likely defer all regulations to the states, maintaining the current framework in a way. In this webinar, a panel of expert industry stakeholders will discuss the practical consequences of this federal crossroads—and how licensed businesses can prepare for the future.
 

Moderator:

 
  • Mason Walker of East Fork Cultivars

Speakers:

 
  • Kris Krane, Founder of 4Front Ventures and CEO of Kranewreck Enterprises
  • Wendy Bronfein, Director of Public Policy at Curio Wellness
  • Jarrod Loadholt, Partner at Ice Miller LLP's Public Affairs Group
Date
Monday, November 7, 2022
Time
1:00 PM
Location
Virtual Webinar

Click here to register for this event.
 
View Full Site View Mobile Optimized